Cite
MLA Citation
Peter M. Voorhees et al.. “Long‐term outcomes for newly‐diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study.” British journal of haematology, vol. 171, n.d., pp. 373–377. http://access.bl.uk/ark:/81055/vdc_100026673138.0x000056